Table 5.

Clinical events

	Standard of care (N = 31)	Alirocumab (N = 30)
Adverse cardiac events	0	0
Cardiac death	0	0
Myocardial infarction	1	0
Ischemia driven target lesion revascularization,
Treatment-related adverse events	1	2
Nasopharyngitis	1	2
Injection-site reaction	0	1
Back pain	1	1
Transaminase elevation